by Maryam Henein, The Tenpenny Report:
Continued from Part 1. Kevin McKernan, a scientist known for his work in genomics, has been sounding the alarm recently on Pfizer’s controversial vaccine production process, and the failure to disclose manufacturing switches from regulators, putting our health at risk – at warp speed.
Let’s continue Part 2 with the long list of issues….
Elderly Population: It’s mentioned that there were no plans to test these vaccine batches on the elderly population, despite the higher risks COVID-19 posed to them.
TRUTH LIVES on at https://sgtreport.tv/
Trial Blinding: The trial was “observer-blinded” rather than “double-blinded,” meaning that those administering the vaccine knew who was receiving it, which could potentially introduce bias.
Batch Variability: There is a speculation about variability in adverse event rates associated with different manufacturing processes (process one and process two) and possibly even within lots from the same process, which might affect the vaccine’s safety profile.
Placebo Group: When those originally in the placebo group started receiving the actual vaccine, there seemed to be a higher rate of adverse events compared to the initial treatment group, which could be due to several factors, including the possibility that they were more likely to report symptoms knowing they received the vaccine.
Lot Numbers and Distribution : According to batch numbers and the distribution to various sites, there is an implication that certain batches may have been linked to a higher incidence of adverse reactions.
Regulatory and Manufacturing Processes: Regulators allowed a change in manufacturing without adequately considering the potential increased risk and without requiring new clinical trials to assess the safety of the vaccines produced with the new method. In the real world, this is an unacceptable scandal. Where is the due diligence, methodological rigor, and transparency in scientific research and communication, especially in matters of public health?
Lipid Nanoparticles : LNPs are a critical component of mRNA vaccines because they encapsulate and protect the mRNA as it is delivered into cells. However, there’s a concern about their toxicity and the impact on the body. For example, McKernan discusses the potential for LNPs to cause adverse effects by transfecting epithelial cells and potentially creating leaky membranes. He also notes that there is a lack of studies regarding the effect of LNPs without mRNA, which leaves a gap in the understanding of their inherent toxicity. (I personally have had no issues finding about the risks and dangers of using LNPs).
Read More @ TheTenpennyReport.com
